The variability of the DXA measurements, both at baseline and over time, were larger in the multiple-dose cohorts than in the single-dose cohorts
Reducing Bias and Improving Experience Clinicians should make every effort to validate the lifelong journey that patients experience with this chronic disease, placing emphasis on person-first language, creating welcoming clinical environments and addressing weight stigmas
Hypoglycemia can be serious and life-threatening if left untreated
however, if the cause has not been eliminated or recovery has not started, they may last for some time
Reduced cravings: NAD+ helps regulate hunger signals, making it easier to control appetite and avoid sugar crashes
Clinical implications Going forward, clinicians may consider integrating GLP-1RAs into the treatment regimens for patients with [RA and obesity], not only to target obesity-related complications but also possibly to target the underlying inflammatory disease process, the authors concluded
